Predicting post-COVID-19 condition in children and young people up to 24 months after a positive SARS-CoV-2 PCR-test:

Manjula D Nugawela1, Terence Stephenson1, Roz Shafran1

  • 1UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.

BMC Medicine
|November 8, 2024
PubMed

Insights

Researchers developed prediction models to identify children and young people (CYP) at high risk of persistent post-COVID-19 condition (PCC) for up to 24 months. Factors like asthma and learning difficulties predict longer-term symptoms, enabling earlier support.

Area of Science:

  • Pediatric Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Post-COVID-19 condition (PCC) affects children and young people (CYP), necessitating identification of those at high risk.
  • Improved prediction of persistent PCC can optimize care pathways for affected CYP.

Purpose of the Study:

  • To develop and validate prediction models for persistent PCC in CYP up to 24 months post-infection.
  • To identify key risk factors associated with long-term PCC in pediatric populations.

Main Methods:

  • Analysis of CYP with PCR-positive results (Sept 2020-Mar 2021) with up to 24-month follow-up.
  • Development of logistic regression models for persistent PCC, defined at 3, 6, 12, 24 months or 6, 12, 24 months.
  • Internal validation using bootstrapping, assessing calibration and discrimination, with adjustments for overfitting.

Main Results:

  • Persistent PCC prevalence was 24.7% at 3 months, decreasing to 7.2% at 6, 12, and 24 months.
  • Key predictors for persistent PCC included female sex, asthma history, allergies, learning difficulties, and family history of ongoing COVID-19.
  • Models demonstrated good calibration (slope 1.064-1.142) and discrimination (C-statistic 0.724-0.755) with minimal overfitting.

Conclusions:

  • Novel prediction models identify CYP at risk for persistent PCC up to 24 months post-infection.
  • These models can aid in triaging CYP and facilitating early support for those with predicted longer-term symptomology.
Abstract